Ethnic Barriers In Type 2 Diabetes
FACULTY
Luigi F. Meneghini, MD, MBAAssociate Professor of Clinical Medicine
Director, Eleanor and Joseph Kosow Diabetes Treatment Center
Associate Director, Diabetes Research Institute
University of Miami Miller School of Medicine
Miami, FL
Read frequently asked questions submitted by your peers.
Newsletter coming in Fall 2008!
 To find out if TiP-TV is offered at your facility, contact
877 438 4788 or e-mail. |
PURPOSE STATEMENT
African-Americans, Hispanic/Latino Americans, American Indians, and Asians are at particularly high risk for the development of type 2 diabetes. This interactive case based Webcast will have leading experts in diabetes discuss the racial and ethnic issues in diabetes care while discussing strategies to ideal management of this growing patient population.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Discuss the epidemiology of diabetes, with particular focus on minority ethnic groups.
- Identify the barriers to optimal diabetes care in various ethnic patient populations
- Explore methods for overcoming identified barriers to achieve optimal glycemic control in these patient populations
TARGET AUDIENCE
This series is intended for primary care providers, certified diabetes educators, nurses, pharmacists, and other healthcare providers who treat patients who are at risk of developing, or currently have diabetes.
ACCREDITATION INFORMATION
Expiration date: June 11, 2009
Physicians: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Med-IQ designates this educational activity for a maximum of
2.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the series.
Nurses (CBRN): Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses. Provider approved by the California Board of Registered Nursing, Provider Number CEP #14745, for 2.0 contact hour(s).
Pharmacists: 
Med-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 2.0 contact hour(s) (0.X0 CEUs) of credit for pharmacists. ACPE #476-000-07-XXX-H01. This program is designed for all pharmacists.
Other Credit Information
Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the series will receive a Statement of Participation indicating the maximum credits available.
Disclosure Policy
It is the policy of Med-IQ that our staff and faculty disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during presentations. Individuals who refuse to disclose will be disqualified from all aspects of this CME activity. Med-IQ has policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
Luigi Meneghini, MD, MBA
Med-IQ Disclosure
Reshma Carter has disclosed that her spouse is an employee of Novartis Pharmaceuticals.
All other employees of Med-IQ have no financial relationships to disclose.
Acknowledgement of Commercial Support
This series is supported by an educational grant from sanofi-aventis U.S.